Pathogenesis of nonimmune glomeralopathies

Annual Review of Pathology

Volumn 1, Issue , 2006, Pages 349-374

  Kwoh, Christopher ^a   Shannon, M Brendan ^a   Miner, Jeffrey H ^a   Shaw, Audrey ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alport syndrome; Glomerular basement membrane; Glomerulosclerosis; Podocyte; Slit diaphragm

Indexed keywords

ALPHA ACTININ; ANGIOTENSIN; CD2 ASSOCIATED PROTEIN; LAMININ; NEPHRIN; PLATELET DERIVED GROWTH FACTOR; PODOCIN; SLIT PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSIENT RECEPTOR POTENTIAL CHANNEL; VASCULOTROPIN; BIOLOGICAL MARKER;

ALPORT SYNDROME; DENYS DRASH SYNDROME; DIABETIC NEPHROPATHY; DISEASE COURSE; ENDOTHELIUM CELL; FOCAL GLOMERULOSCLEROSIS; GENETIC DISORDER; GLOMERULUS BASEMENT MEMBRANE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPERTENSION; KIDNEY INJURY; MESANGIUM CELL; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; REVIEW; ANIMAL; CELL PROLIFERATION; DISEASE MODEL; MESANGIUM; METABOLISM; PATHOLOGY;

ANIMALS; BIOLOGICAL MARKERS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GLOMERULAR BASEMENT MEMBRANE; GLOMERULAR MESANGIUM; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; PODOCYTES;

EID: 33645733358     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev.pathol.1.110304.100119     Document Type: Review

References (124)

1. Collins AJ, Kasiske B, Herzog C, Chavers B, Foley R, et al. 2005. USRDS 2004 Annual data report. Am. J. Kidney Dis. 45:A5-7
2. Kriz W, Elger M, Nagata M, Kretzler M, Uiker S, et al. 1994. The role of podocytes in the development of glomerular sclerosis. Kidney Int. 45:S64-S72
3. Kriz W, Hartmann I, Hosser H, Hahnel B, Kranzlin B, et al. 2001. Tracer studies in the rat demonstrate misdirected filtration and peritubular filtrate spreading in nephrons with segmental glomerulosclerosis. J. Am. Soc. Nephrol. 12:496-506
4. Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, et al. 2001. Impaired angiogenesis in the rat remnant kidney model. J. Am. Soc. Nephrol. 12:1434-47
5. Lee LK, Meyer TW, Pollock AS, Lovett DH. 1995. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J. Clin. Invest. 96:953-64
6. Kitamura H, Shimizu A, Masuda Y, Ishikazi M, Sugisaki Y, et al. 1998. Apoptosis in glomerular endothelial cells during the development of glomerulosclerosis in the remnant kidney model. Exp. Nephrol. 6:328-36
7. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, et al. 1992. Glomerular cell proliferation and PDGF expression precede glomerular sclerosis in the rat remnant kidney model. Kidney Int. 41:297-309
8. Boute N, Gribouval O, Boute N, Sich M, Benessy F, et al. 2000. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid resistant nephrotic syndrome. Nat. Genet. 24:349-54
9. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, et al. 2001. Mutations in ACTN4, encoding alpha actinin 4, cause familial focal segmental glomerulosclerosis. Nat. Genet. 24:251-56
10. Shih NY, Li J, Karpitskii V, Nguyen A, Dustin ML, et al. 1999. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 286:312-15
11. Kang DH, Hughes J, Mazzali M, Schreiner GF, Johnson RJ. 2001. Impaired angiogenesis in the rat remnant kidney model. Administration of VEGF reduces renal fibrosis and stabilizes renal function. J. Am. Soc. Nephrol. 12:1448-57
12. Meyer TW, Bennett PH, Nelson RG. 1999. Podocyte number predicts long term urinary albumin excretion in Pima Indians with type II diabetes and microalbuminuria. Diabetilogia 42:1341-44
13. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Meyers BD, et al. 1997. Podocyte loss and progressive glomerular injury in Type II diabetes. J. Clin. Invest. 99:342-48
14. Brenner BM. 1985. Nephron adaptation to renal injury or ablation. Am. J. Physiol. Renal Physiol. 249:F324-F337
15. Abbate M, Zoja C, Morigi M, Rottoli D, Angioletti S, et al. 2002. Transforming growth factor beta is upregulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis. Am. J. Pathol. 161:2179-93
16. Shulman K, Rosen S, Tognazzi K, Manseau EJ, Brown LF. 1996. Expression of vascular permeability factor (VEGF) is altered in many glomerular diseases. J. Am. Soc. Nephrol. 7:661-66
17. Kriz W, Hosser H, Hahnel B, Gretz N, Provoost AP. 1998. From segmental glomerulosclerosis to total nephron degeneration and interstitial fibrosis: A histopathological study in rat models and human glomerulopathies. Nephrol. Dial. Transplant. 13:2781-98
18. Deleted in proof
19. Rennke HG. 1994. How does glomerular epithelial cell injury contribute to progressive glomerular damage? Kidney Int. 45:S58-S63
20. Lahdenkari AT, Lounatmaa K, Patrakka J, Holmberg C, Wartiovaara J, et al. 2004. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria. Am. Soc. Nephrol. 15:2611-18
21. Saborio P, Scheinman JI. 1999. Sickle cell nephropathy. J. Am. Soc. Nephrol. 10:187-92
22. Rodewald R. 1974. Porous substructure of the glomerular slit diaphragm in the rat and mouse. J. Cell Biol. 60:423-33
23. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, et al. 1998. Positionaly cloned gene for a novel glomerular protein "nephrin" is mutated in congenital nephrotic syndrome. Mol. Cell. 1:575-82
24. Sellin L, Huner TB, Gerke P, Quack I, Pavenstadt H, et al. 2003. NEPH1 defines a novel family of podocin interacting proteins. FASEB J. 17:115-17
25. Donoviel DB, Freed DD, Vogel H, Potter DG, Hawkins E, et al. 2001. Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to nephrin. Mol. Cell. Biol. 21:4829-36
26. Wartiovaara J, Ofverstedt LG, Khoshnoodi J, Zhang J, Makela E, et al. 2004. Nephrin strands contribute to a porous slit diaphragm scaffold as revealed by electron tomography. J. Clin. Invest. 10:475-1483
27. Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, et al. 2001. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J. Clin. Invest. 108:1621-29
28. Huber TB, Hartleben B, Kim J, Schmidts M, Schermer B, et al. 2003. Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol. Cell. Biol. 23:4917-28
29. Kos C, Le TC, Sinha S, Henderson JM, Kim SH, et al. 2003. Mice deficient in alpha-actinin 4 have severe glomerular disease. J. Clin. Invest. 111:1683-90
30. Roselli S, Gribouval O, Boute N, Sich M, Benessy F, et al. 2002. Podocin localizes in the kidney to the slit diaphragm area. Am. J. Pathol. 160:131-39
31. Holmberg C, Antikainen M, Ronnholm K, Ala Houhala M, Jalanko H. 1995. Management of congenital nephrotic syndrome of the Finnish type. Pediatr. Nephrol. 9:87-93
32. Lenkkeri U, Mannikko M, McCready P, Lamerdin J, Gribouval O, et al. 1999. Structure of the gene for congenital nephrotic syndrome of the Finnish type (NPHS1) and characterization of mutations. Am. J. Hum. Genet. 64:51-61
33. Pattrakka J, Kestila M, Wartiovaara J, Ruotsalainen V, Tissari P, et al. 2000. Congenital nephrotic syndrome (NPHS1): Features resulting from different mutations in Finnish patients. Kidney Int. 58:972-80
34. Liu L, Done SC, Khoshnoodi J, Bertorello A, Wartiovaara J, et al. 2001. Defective nephrin trafficking caused by missense mutations in the NPHSI gene: Insight into the mechanisms of congenital nephrotic syndrome. Hum. Mol. Genet. 10:2637-34
35. Liu XL, Done SC, Yan K, Kilpelainen P, Pikkarainen T, Tryggvason K. 2004. Defective trafficking of nephrin missense mutants rescued by a chemical chaperone. J. Am. Soc. Nephrol. 15:1731-38
36. Putaala H, Soininen R, Kilpelainen P, Wartiovaara J, Tryggvason K. 2001. The murine nephrin gene is specifically expressed in kidney, brain, and pancreas. Inactivation of the gene leads to massive proteinuria and neonatal death. Hum. Mol. Genet. 10:1-8
37. Caridi G, Bertelli R, DiDuca M, Dagnino M, Emma F, et al. 2003. Broadening the spectrum of diseases related to podocin mutations. J. Am. Soc. Nephrol. 14:1278-86
38. Tsukaguchi H, Sudhakar A, Le TC, Nguyen T, Yao J, et al. 2002. NPHS2 mutations in late onset focal segmental glomerulosclerosis: R229Q is a common disease associated allele. J. Clin. Invest. 110:1654-66
39. Huber TB, Simons M, Hartleben B, Semetz L, Schmidts M, et al. 2003. Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to the lipid raft microdomains. Hum. Mol. Genet. 12:3397-3405
40. Nishibori Y, Liu L, Hosoyamada M, Endou H, Kudo A, et al. 2004. Disease-causing missense mutations in NPHS2 gene alter normal nephrin trafficking to the plasma membrane. Kidney Int. 66:1755-65
41. Roselli S, Heidet L, Sich M, Henger A, Kretzler M, et al. 2004. Early glomerular filtration defect and severe renal disease in podocin deficient mice. Mol. Cell. Biol. 24:550-60
42. Araki N, Hatae T, Yamada T, Hirohashi S. 2000. Actinin-4 is preferentially involved in circular ruffling and macropinocytosis in mouse macrophages. J. Cell. Sci. 113:3329-40
43. Yao J, Le TC, Kos CH, Henderson JM, Allen PG, et al. 2004. Alpha actinin 4 mediated FSGS: An inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein. PLoS Biol. 2:787-94
44. 43a. Grunkemeyer J, Kwoh C, Huber T, Shaw A. 2005. CD2AP expression in podocytes rescues lethality of CD2AP deficiency. J. Biol. Chem. 280(33):29677-81
45. Kim JM, Wu H, Green G, Winkler CA, Kopp JB, et al. 2003. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 300:1298-1300
46. Schiffer M, Mundel P, Shaw AS, Bottinger EP. 2004. A novel role for the adapter molecule CD2 associated protein in TGF-B induced apoptosis. J. Biol. Chem. 279:37004-37012
47. 45a. Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, et al. 2005. A mutation in the TRPC6 cation channel causes familial segmental glomerulosclerosis. Science 308:1801-4
48. 45b. Reiser J, Polu KR, Moller CC, Kenlan P, Altintas MM, et al. 2005. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat. Genet. 37:739-44
49. Soubeyran P. 2002. Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature 416:183-87
50. Verma R, Wharram B, Kovari I, Kunkel R, Nihalani D, et al. 2003. Fyn binds to and phosphorylates the slit diaphragm component nephrin. J. Biol. Chem. 278:20716-23
51. Li H, Lemay S, Aoudjit L, Kawachi H, Takano T. 2004. Src-family kinase fyn phosphorylates the cytoplasmic domain of nephrin and modulates it interaction with podocin. J. Am. Soc. Nephrol. 15:3006-15
52. Huber TB, Kottgen M, Schilling B, Walz G, Benzing T. 2001. Interaction with podocin facilitates nephrin signaling. J. Biol. Chem. 276:41543-46
53. Liu XL, Kilpelainen P, Hellman U, Sun Y, Wartiovaara J, et al. 2005. Characterization of the interactions of the nephrin intracellular domain: Evidence that the scaffolding protein IQGAP1 associates with nephrin. FEBS J. 272:228-43
54. 50a. Hisatsune C, Kuroda Y, Nakamura K, Inoue T, Nakamura T, et al. 2003. Regulation of TRPC6 channel activity by tyrosine phosphorylation. J. Biol. Chem. 278:20716-23
55. Remuzzi G, Chiurchiu C, Ruggenenti P. 2004. Proteinuria predicting outcome in renal disease. Kidney Int. 92:S90-96
56. Davies D, Messina A, Thumwood CM, Ryan GB. 1985. Glomerular podocytic injury in protein overload proteinuria. Pathology 17:412-19
57. Schiffer M, Schiffer LE, Gupta A, Shaw AS, Roberts IS, et al. 2002. Inhibitory Smads and TGF-B signaling in glomerular cells. J. Am. Soc. Nephrol. 13:2657-66
58. Schiffer M, Bitzer M, Roberts IS, Kopp JB, ten Dijke P, et al. 2001. Apoptosis in podocytes induced by TGF-B and Smad 7. J. Clin. Invest. 108:807-16
59. Imai E, Isaka Y, Fujiwara Y, Kaneda Y, Kamada T, Ueda N. 1994. Introduction of a foreign gene into the kidney in vivo: Development of glomerulosclerosis by the transfection of gene for PDGF and TGF-β. Contrib. Nephrol. 107:205-15
60. Schnaper H, Hayashida T, Hubchak SC, Poncelet AC. 2003. TGF β signal induction and mesangial cell fibrogenesis. Am. J. Physiol. Renal. Physiol. 284:243-52
61. Ito T, Suzuki A, Imai E, Okabe M, Hori M. 2001. Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. J. Am. Soc. Nephrol. 12:2625-35
62. Mooney A, Jackson K, Bacon R, Streuli C, Edwards G, et al. 1999. Type IV collagen and laminin regulate glomerular mesangial cell susceptibility to apoptosis via beta-1 integrin mediated survival signals. Am. J. Pathol. 155:599-606
63. Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, Shortland J, Brown CB, el Nahas AM. 1997. Myofibroblasts and the progression of diabetic nephropathy. Nephrol. Dial. Transplant. 12:43-50
64. Hudkins KL, Gilbertson DG, Carling M, Taneda S, Hughes SD, et al. 2004. Exogenous PDGF-D is a potent mesangial cell mitogen and causes a severe mesangial proliferative glomerulopathy. J. Am. Soc. Nephrol. 15:286-98
65. Suzuki A, Iwatani H, Ito T, Imai E, Okabe M, et al. 2004. Platelet derived growth factor plays a critical role to convert bone marrow cells into glomerular mesangial-like cells. Kidney Int. 65:15-24
66. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, et al. 2003. Glomerular specific alterations of VEGF-A expression lead to congenital and acquired glomerular disease. J. Clin. Invest. 111:707-16
67. Ruggenenti P. 2004. ACE inhibition and AT II antagonism in nondiabetic chronic nephropathies. Semin. Nephrol. 24:158-167
68. Durvasula RV, Petermann AT, Hiromura K, Blonski M, Pippin J, et al. 2004. Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int. 65:30-39
69. Gloy J, Henger A, Fischer KG, Nitschke R, Mundel P, et al. 1997. Angiotensin II depolarizes podocyte in the intact glomerulus of the rat. J. Clin. Invest. 99:2772-81
70. Sharma R, Lovell HB, Wiegmann TB, Savin VJ. 1992. Vasoactive substances induce cytoskeletal changes in cultured rat glomerular epithelial cells. J. Am. Soc. Nephrol. 3:1131-38
71. Ding G, Reddy K, Kapasi AA, Franki N, Gibbons N, et al. 2002. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am. J. Physiol. Renal Physiol. 283:F173-F180
72. Hoffmann S, Podlich D, Hahnel B, Kriz W, Gretz N. 2004. Angiotensin II type I receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J. Am. Soc. Nephrol. 15:1475-87
73. Marras D, Bruggeman LA, Gao F, Tanji N, Mansukhani MM, et al. 2002. Replication and compartmentalization of HIV-1 in kidney epithelium in patients with HIV-associated nephropathy. Nat. Med. 8:522-26
74. Alpers C, McClure J, Bürsten SL. 1992. Human mesangial cells are resistant to multiple strains of human immuno deficiency virus strains 1 and 2. Am. J. Kidney Dis. 19:126-30
75. Green DF, Resnick L, Bourgoignie JJ. 1992. HIV infects glomerular endothelial and mesangial cells, but not epithelial cells in vitro. Kidney Int. 41:1956-60
76. Dickie P, Felser J, Eckhaus M, Bryant J, Silver J, et al. 1991. HIV associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185:109-19
77. Dickie P, Roberts A, Uwiera R, Witmer J, Sharma K, Kopp JB. 2004. Focal glomerulosclerosis in proximal and c-fms transgenic mice links Vpr expression to HIV associated nephropathy. Virology 322:69-81
78. He JC, Husain M, Sunamoto M, D'Agati VD, Klotman ME, et al. 2004. Nef stimulates proliferation of glomerular podocytes through activation of src dependent Stat3 and MAPK1,2 pathways. J. Clin. Invest. 114:643-51
79. Barisoni L, Kriz W, Mundel P, D'Agati V. 1999. The dysregulated podocyte phenotype: a novel concept in the pathogenensis of collapsing idiopathic focal segmental glomerulosclerosis and HIV associated nephropathy. J. Am. Soc. Nephrol. 10:51-61
80. Bariety J, Nochy D, Mandet C, Jacquot C, Glotz D, Meyrier A. 1998. Podocytes undergo phenotypic change and express macrophage-associated markers in idiopathic collapsing glomerulopathy. Kidney Int. 53:918-25
81. Bodi I, Kimmel PL, Abraham AA, Svetkey LP, Klotman PE, Kopp JB. 1997. Renal TGF-B in HIV-associated kidney disease. Kidney Int. 51:1568-77
82. Barisoni L, Kopp JB. 2002. Modulation of podocyte phenotype in collapsing glomerulopathy. Microsc. Res. Tech. 57:254-62
83. Mrowka C, Schedl A. 2000. Wilm's tumor suppressor gene WT-1: From structure to renal pathophysiologic features. J. Am. Soc. Nephrol. 11:S106-S115
84. Yang AH, Chen JY, Chen BF. 2004. The dysregulated glomerular cell growth in Denys-Drash syndrome. Virchows Arch. 445:305-14
85. Wendt TM, Tanji N, Quo J, Kislinger TR, Qu W, et al. 2003. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am. J. Pathol. 162:1123-37
86. Hirschberg R, Brunori G, Kopple JD, Guler HP. 1993. Effects of IGF-1 on renal function in normal men. Kidney Int. 43:387-97
87. Sabbatini M, Sansone G, Uccello F, Giliberti A, Conte G, Andreucci VE. 1992. Early glycosylation products induce glomerular hyperfiltration in diabetes mellitus. Kidney Int. 42:875-81
88. Wolf G, Schroeder R, Ziyadeh FN, Thaiss F, Zahner G, Stahl RA. 1997. High glucose stimulates expression of p27 in cultured mouse mesangial cells: Relationship to hypertrophy. Am. J. Physiol. 273:348-56
89. Hoffman BB, Sharma K, Zhu Y, Ziyadeh FN. 1998. Transcriptional activation of TGF-B in mesangial cell culture by high glucose concentration. Kidney Int. 58:1107-16
90. Singh R, Alavi N, Singh AK, Leehey DJ. 1994. Role of angiotensin II in glucose mediated inhibition of mesangial matrix degradation. Diabetes 48:2066-73
91. Yan SF, Ramasamy R, Naka Y, Schmidt AM. 2003. Glycation, inflammation, and RAGE. Circ. Res. 93:1159-69
92. Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, et al. 2001. Development and prevention of diabetic nephropathy in RAGE overexpressing mice. J. Clin. Invest. 108:261-68
93. 88a. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, et al. 2000. Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol. Dial. Transplant. 15:1379-83
94. 88b. Regoli M, Bendayan M. 1997. Alterations in the expression of the alpha 3 beta 1 integrin in certain membrane domains of the glomerular epithelial cells (podocytes) in diabetes mellitus. Diabetologia 40:15-22
95. Ihm C, Park JK, Hong SP, Lee TW, Cho BS, et al. 1998. High glucose stimulates MCP-1 in human mesangial cells. Nephron 79:33-37
96. Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S, et al. 2003. The pattern recognition receptor (RAGE) is a counter receptor for leukocyte integrins: a novel pathway for inflammatory cell recuritment. J. Exp. Med. 198:1507-15
97. Adler S. 2004. Diabetic nephropathy: Linking histology, cell biology, and genetics. Kidney Int. 66:2095-2106
98. Barker D, Hostikka S, Zhou J, Chow LT, Oliphassnt AR, et al. 1990. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248:1224-26
99. Mochizuki T, Lemmink H, Mariyama M, Antignac C, Gubler MC, et al. 1994. Identification of mutations in the α3 (IV) and α4(IV) collagen genes in autosomal recessive Alport syndrome. Nature Genet. 8(1):77-82
100. van der Loop F, Heidet L, Timmer ED, van den Bosch BJ, Leinonen A, et al. 2000. Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney Int. 58(5):1870-75
101. Spear G, Slusser R. 1972. Alport's syndrome: emphasizing electron microscopic studies of the glomerulus. Am. J. Pathol. 69(2):213-24
102. Rumpelt H. 1987. Alport's syndrome: specificity and pathogenesis of glomerular basement membrane alterations. Pediatr. Nephrol. 1(3):422-27
103. Antonovych T, Deasy P, Tina LU, D'Albora JB, Hollerman CE, Calcagno PL. 1969. Hereditary nephritis: early clinical, functional and morphological studies. Pediatr. Res. 3(6):545-56
104. Hudson B, Tryggvason K, Sundaramoorthy M, Neilson EG. 2003. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N. Engl. J. Med. 348(25):2543-56
105. Miner J, Sanes J. 1994. Collagen IV alpha 3, alpha 4, and alpha 5 chains in rodent basal laminae: sequence, distribution, association with laminins, and developmental switches. J. Cell Biol. 127(3):879-91
106. Harvey S, Zheng K, Sado Y, Naito I, Ninomiya Y, et al. 1998. Role of distinct type IV collagen networks in glomerular development and function. Kidney Int. 54(6):1857-66
107. Kalluri R, Shield C, Todd P, Hudson BG, Neilson EG. 1997. Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J. Clin. Invest. 99(10): 2470-78
108. Nakanishi K, Yoshikawa N, Iijima K, Kitagawa K, Nakamura H, et al. 1994. Immunohistochemical study of α1-5 chains of type IV collagen in hereditary nephritis. Kidney Int. 46(5):1413-21
109. Miner J, Sanes J. 1996. Molecular and functional defects in kidneys of mice lacking collagen α3(IV): Implications for Alport syndrome. J. Cell. Biol. 135(5):1403-13
110. Cosgrove D, Meehan DT, Grunkemeyer JA, Kornak JM, Sayers R, et al. 1996. Collagen COL4A3 knockout: a mouse model for Alport syndrome. Genes Dev. 10(23):2981-92
111. Andrews K, Mudd J, Li C, Miner JH. 2002. Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome. Am. J. Pathol. 160(2):721-30
112. Gunwar S, Ballester F, Noelken ME, Sado Y, Ninomiya Y, Hudson BG. 1998. Glomerular basement membrane. Identification of a novel disulfide-cross-linked network of α3, α4 and α5 chains of type IV collagen and its implications for the pathogenesis of Alport syndrome. J. Biol. Chem. 273(15):8767-75
113. Abrahamson D, Prettyman A, Robert B, St John PL. 2003. Laminin-1 reexpression in Alport mouse glomerular basement membranes. Kidney Int. 63(3):826-34
114. Kashtan C, Kim Y, Lees GE, Thorner PS, Virtanen I, Miner JH. 2001. Abnormal glomerular basement membrane laminins in murine, canine and human Alport syndrome: Aberrant laminin α2 deposition is species independent. J. Am. Soc. Nephrol. 12(2):252-60
115. Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY. 2003. Thin basement membrane nephropathy. Kidney Int. 64(4):1169-78
116. Lemmink H, Nillesen W, Mochizuki T, Schroder CH, Brunner HG, et al. 1996. Benign familial hematuria due to mutation of the type IV collagen α4 gene. J. Clin. Invest. 98(5):1114-18
117. Buzza M, Wilson D, Savige J. 2001. Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome. Kidney Int. 59(5):1670-76
118. Sterk LMT, Geuijen CA, van den Berg JG, Claessen N, Weening JJ, Sonnenberg A. 2002. Association of the tetraspanin CDl51 with the laminin-binding integrins {alpha}3{beta}1, {alpha}6{beta}1, {alpha}6{beta}4 and {alpha}7{beta}1 in cells in culture and in vivo. J. Cell. Sci. 115(6):1161-73
119. Karamatic Crew V, Burton N, Kagan A, Green CA, Levene C, et al. 2004. CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes, is essential for the correct assembly of human basement membranes in kidney and skin. Blood 104:2217-23
120. Zenker M, Aigner T, Wendler O, Tralau T, Muntefering H, et al. 2004. Human laminin {beta}2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum. Mol. Genet. 13:2625-32
121. Noakes P, Miner J, Gautam M, Cunningham JM, Sanes JR, Merlie JP. 1995. The renal glomerulus of mice lacking s-laminin/laminin B2: nephrosis despite molecular compensation by laminin B1. Nature Genet. 10(4):400-406
122. Dreyer S, Zhou G, Baldini A, Winterpacht A, Zabel B, et al. 1998. Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat. Genet. 19(1):47-50
123. Morello R, Zhou G, Dreyer SD, Harvey SJ, Ninomiya Y, et al. 2001. Regulation of glomerular basement membrane collagen expression by LMX1B contributes to renal disease in nail patella syndrome. Nature Genet. 27(2):205-208
124. Miner JH, Morello R, Andrews KL, Li C, Antignac C, et al. 2002. Transcriptional induction of slit diaphragm proteins by Lmx1b is required in podocyte differentiation. J. Clin. Invest. 109(8):1065-72